$1M Trimmed From $4.8M Award Over Remicade Ads

Law360, New York (March 9, 2010, 2:18 PM EST) -- A Texas appeals court has stripped $1 million from a $4.8 million award to a couple who claimed Johnson & Johnson Inc. subsidiary Centocor Inc.'s advertising misled them into thinking its Remicade drug was safe.

The Texas Court of Appeals for the Thirteenth District sustained the drug company's challenge to a $1 million award of future damages Thursday, saying plaintiffs Patricia and Thomas Hamilton failed to prove such damages at trial.

But the ruling affirmed the central conclusion of a Nueces County jury, which found Centocor...
To view the full article, register now.